Supplementary Materials

This PDF file includes:

  • Materials and Methods
  • Fig. S1. Reactogenicity bar charts for HVTN 097.
  • Fig. S2. IgG binding antibody responses to cross-clade V1V2 antigens among vaccine recipients in the per-protocol cohorts of HVTN 097 and RV144 at the peak immunogenicity time point.
  • Fig. S3. IgG3 binding antibody responses to gp120 antigens among vaccine recipients in the per-protocol cohorts of HVTN 097 and RV144 at the peak immunogenicity time point.
  • Fig. S4. Neutralizing antibody responses in the per-protocol cohorts of HVTN 097 and RV144 at the peak immunogenicity time point.
  • Table S1. Comparison of ICS (IL-2+ and/or IFN-γ+) CD4+ and CD8+ T cell responses to Env at the peak immunogenicity time point among vaccine recipients in the per-protocol cohorts of HVTN 097 and RV144.
  • Table S2. Details of the BAMA, ICS, neutralizing antibody, ADCC, and ADCP antigens including HIV-1 viral strain information.
  • Table S3. Response rates among vaccine recipients in the per-protocol cohorts of HVTN 097 and RV144 for IgG and IgG3 binding antibody and neutralizing antibody responses at the peak immunogenicity time point.
  • Table S4. IgG binding antibody response among vaccine recipients in the per-protocol cohorts of HVTN 097 and RV144 at the peak immunogenicity time point by age, sex, and BMI.
  • References (48, 49)

[Download PDF]